Prof. Jo Nijs and colleagues at Vrije Universiteit Brussel and other centres in Belgium have recently published more findings from their ME Research UK-funded study looking at the potential role of epigenetics in ME/CFS.
These results focus on COMT, which is an enzyme known to have effects on pain and inflammation.